British scientists have come up with condoms that lead to increased potency. The world-known company SSL International, which owns the Durex brand, will issue new condoms.
Condoms CSD500 are treated with a gel that contains nitroglycerin. Nitroglycerin is a medicament widely used for the treatment of angina pectoris, which is manifested by the pain behind the sternum, which is due to the narrowing of the blood vessels. Nitroglycerin has a unique ability to expand the blood vessels, including the vessels of the penis. When using CSD500 condoms, nitroglycerin is absorbed through the skin of the penis and penetrates into the blood vessels, causing them to expand. In turn, the expansion of the vessels leads to an increase in blood flow to the penis and increase the potency.
According to the instructions for new condoms, their use is indicated for the treatment of erectile dysfunction, and not for the correction of erectile dysfunction. Erectile dysfunction occurs most often in the elderly and elderly, and for its treatment requires the use of Viagra. Weakness of erection is a common sexual disorder, which occurs mainly in young people. It is for men of a young age that new condoms with nitroglycerin CSD500 are designed.